Chemoinformaics analysis of 13-Isobutyryloxylupanine
| Molecular Weight | 334.46 | nRot | 2 |
| Heavy Atom Molecular Weight | 304.22 | nRig | 22 |
| Exact Molecular Weight | 334.226 | nRing | 4 |
| Solubility: LogS | -1.945 | nHRing | 4 |
| Solubility: LogP | 2.086 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 54 | No. of Aliphatic Hetero Cycles | 4 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 4 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 56.3398 |
| nHD | 0 | BPOL | 36.9882 |
| QED | 0.725 |
| Synth | 4.702 |
| Natural Product Likeliness | 1.167 |
| NR-PPAR-gamma | 0.011 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.051 |
| Pgp-sub | 0.011 |
| HIA | 0.002 |
| CACO-2 | -4.705 |
| MDCK | 0.0000358 |
| BBB | 0.513 |
| PPB | 0.245868 |
| VDSS | 0.987 |
| FU | 0.744847 |
| CYP1A2-inh | 0.012 |
| CYP1A2-sub | 0.046 |
| CYP2c19-inh | 0.024 |
| CYP2c19-sub | 0.795 |
| CYP2c9-inh | 0.003 |
| CYP2c9-sub | 0.123 |
| CYP2d6-inh | 0.483 |
| CYP2d6-sub | 0.588 |
| CYP3a4-inh | 0.127 |
| CYP3a4-sub | 0.622 |
| CL | 12.688 |
| T12 | 0.247 |
| hERG | 0.035 |
| Ames | 0.009 |
| ROA | 0.012 |
| SkinSen | 0.805 |
| Carcinogencity | 0.727 |
| EI | 0.021 |
| Respiratory | 0.261 |
| NR-Aromatase | 0.003 |
| Antiviral | Yes |
| Prediction | 0.82969 |